Dr. Green is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
Carlton St & Elm St
Buffalo, NY 14263Phone+1 716-845-7110
Education & Training
Indiana University School of MedicineFellowship, Hematology and Medical Oncology, 2018 - 2021- Indiana University School of MedicineResidency, Internal Medicine, 2015 - 2018
- Indiana University School of MedicineClass of 2015, MD
Indiana UniversityBS, Biotechnology, 2007 - 2011
Certifications & Licensure
NY State Medical License 2021 - 2026
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- CPX-351 for the Treatment of Secondary Acute Myeloid Leukemia in Patients Younger Than 60 Years Old Start of enrollment: 2021 Jul 29
Roles: Contact, Principal Investigator
Publications & Presentations
PubMed
- Optimal therapeutic strategies in relapsed/refractory AML with prior exposure to venetoclax-based therapy.Sawyer Bawek, Matthew Burwinkel, Prutha Patel, Katy Wang, Kristopher Attwood
Leukemia Research. 2025-01-13 - Significance of cycle 1 bone marrow biopsy in predicting outcomes and toxicities of venetoclax-based therapy for myeloid malignancies.Jeffrey Baron, Daniel Appiah, Mark G Faber, Han Yu, Tara Cronin
Leukemia & Lymphoma. 2024-12-27 - 1 citationsHow I Treat: Secondary Acute Myeloid Leukemia.Steven D Green, Eunice S Wang
Blood. 2024-10-02
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
